We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
China New Energy Limited | CNEL | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
7.50 | 7.50 |
Top Posts |
---|
Posted at 19/3/2021 08:54 by nick of the north Results to be announced on 24th March along with dividend, if any. |
Posted at 09/10/2020 13:59 by aimmafia You've had a shocker- cnel has always been a dog |
Posted at 11/8/2020 08:48 by nick of the north "The board of directors (the “Board”) of China New Energy Limited (the “Company&rdquo |
Posted at 14/7/2020 12:04 by doyourresearch MMs holding CNEL at close of play today will be forced to wait several weeks to sell their converted HKEX position. No MM is up for that so they just set the spread at ridiculous levels to stop any buy/sell activityI wonder if all UK converted holders of HKEX stock will be notified that their new shares are available to sell at the same time or will some brokers be able to act quicker than others? |
Posted at 11/7/2020 08:33 by killman2 If I have done my sums right, out of the 11 firms listing in HK last week 8 are now in profit whilst only 3 are negative. Would like to think the HK investor appreciates new companies coming onto their bourse and invests confidently...CNEL next week hits at the right time....imhoCode Stock Date Range IPO Current P/L 1957 MBV International 08/07/2020 0.80-0.88 0.8 0.335 -58% 8623 China Saftower 10/07/2020 0.25-0.4 0.3 0.217 -28% 9989 SHENZHEN HEPALINK 08/07/2020 18.4-20.6 18.4 17.48 -5% 1971 Redsun Services 07/07/2020 3.3-4.3 4.15 4.27 3% 6958 ZHENRO SERVICES 10/07/2020 3.6-4.7 4.55 5.6 23% 1163 ADTIGER CORPORATIONS 10/07/2020 0.84-1 0.86 1.07 24% 9979 GREENTOWN MANAGEMENT 10/07/2020 2.2-3 2.5 3.25 30% 1502 FINANCIAL STREET 06/07/2020 7.16-7.56 7.36 10.24 39% 6978 Immunotech Biopharm Ltd 10/07/2020 10.5-11 11 15.48 41% 6969 Smoore International Ho 10/07/2020 9.6-12.4 12.4 31 150% 1477 Ocumension Therapeutics 10/07/2020 13.16-14.66 14.66 37 152% |
Posted at 10/7/2020 20:09 by fart_conductor Ok so they have raised HK$105m that's now fact, over subscribed 2.5x, the only thing that could have thwarted at this late late stage, the HKSE Calendar has them listing on the 15th,without an rns CNEL appear to have fulfilled their criteria and surpassed any timeline for rejection, so i assume it's just a case of getting an official procedural stamp as it were at a HKSE's schedule next week |
Posted at 10/7/2020 06:54 by killman2 Looks set for a x2 listing. You can get the Listing Price below and also see what the latest listing have done for compatison. CNEL is x2.5 oversubscribed so demand is there just depends on the market conditions.Picked out YEAHKA LIMITED which listed on 2020-06-01 at 16.64 and is now HKD41.85 with a daily rise of 1.85 4.63% and range between 40 - 46 after just over a month on the market... ...here's hoping CNEL goes the same way...got them all crossed Lots of interesting info at hxxp://www.utrade.co hxxp://www.poems.com hxxp://www.poems.com |
Posted at 09/7/2020 18:12 by scar If you look at the calendar for the 15th of July on hkex you'll see new listing for cnel |
Posted at 08/6/2020 07:51 by trusty hxxps://simplywall.s |
Posted at 06/6/2020 10:16 by ajvr1 Hi all, new to this site/chat.Just wondering if there are any old timers (e.g long hold investors) still here? Just spent an hour or two reading old posts on here for CNEL and have finally caught up to the latest post. Wanted to know the old timers thoughts on recent stuff happening. As it seemed most were upset with CNEL not releasing any news/PR/directors not buying etc or even annoyed at the share price. Are your thoughts still the same? Or have they prospered with a more postive outlook? Or have you given up in total and sold the shares (although i know you might not admit to that one) Thanks. Aj |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions